MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

CONMED Company Profile (NASDAQ:CNMD)

Consensus Ratings for CONMED (NASDAQ:CNMD) (?)
Ratings Breakdown: 2 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $55.00 (32.79% upside)

Analysts' Ratings History for CONMED (NASDAQ:CNMD)
Show:
DateFirmActionRatingPrice TargetActions
4/28/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Needham & Company LLCBoost Price TargetBuy$48.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2015Northland SecuritiesLower Price TargetMarket Perform$58.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/12/2015Ladenburg ThalmannUpgradeNeutral -> Buy$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2015Piper JaffrayReiterated RatingNeutral$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Northland Capital PartnersInitiated CoverageOutperform$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015KeyBancInitiated CoverageSector WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Summer StreetBoost Price TargetBuy$46.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/2/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha